Jianyou Co., Ltd. (603707.SH) subsidiary product Vitamin B1 Injection receives U.S. FDA approval

Zhitong Finance APP News, Jianyou Co., Ltd. (603707.SH) announced that its subsidiary Hong Kong Jianyou Industrial Co., Ltd. (hereinafter referred to as "Hong Kong Jianyou") recently received an ANDA approval notice from the U.S. Food and Drug Administration (hereinafter referred to as "U.S. FDA") for Vitamin B1 Injection 200mg/2mL (100mg/mL) (ANDA No.: 213131). The newly approved product further enriches the company's international product pipeline and strengthens the company's international market layout. If subsequent launch and sales in the U.S. market are advanced, it is expected to have a positive impact on the company's operating performance.